Literature DB >> 18269190

Angiotensin-induced hypoxia in the kidney: functional and structural changes of the renal circulation.

Masaomi Nangaku1, Reiko Inagi, Toshio Miyata, Toshiro Fujita.   

Abstract

Recent studies emphasize the role of chronic hypoxia in the kidney as a final common pathway to end-stage renal disease (ESRD). Hypoxia of tubular cells leads to apoptosis or epithelial-mesenchymal transdifferentiation. This in turn exacerbates fibrosis of the kidney with loss of peritubular capillaries and subsequent chronic hypoxia, setting in train a vicious cycle whose end point is ESRD. To support this notion, our studies utilizing various techniques such as hypoxia-sensing transgenic rats revealed hypoxia of the kidney in various disease models. While fibrotic kidneys with advanced renal disease are devoid of peritubular capillary blood supply and oxygenation to the corresponding region, imbalances in vasoactive substances and associated intrarenal vasoconstriction can cause chronic hypoxia even at the early phase of kidney disease. Among various vasoactive substances, local activation of RAS is especially important because it can lead to constriction of efferent arterioles, hypoperfusion of postglomerular peritubular capillaries, and subsequent hypoxia of the tubulointerstitium in the downstream compartment. Recent studies using BOLD-MRI showed an immediate decrease of oxygen tension in the kidney after angiotensin II infusion. In addition, angiotensin II induces oxidative stress via activation of NADPH oxidase. Oxidative stress damages endothelial cells directly, causing the loss of peritubular capillaries. Oxidative stress also results in relative hypoxia due to inefficient cellular respiration. Thus, angiotensin II induces renal hypoxia via both hemodynamic and nonhemodynamic mechanisms. While the beneficial effects of blockade of RAS in kidney disease are, at least in part, mediated by amelioration of hypoxia, recent studies have also elucidated the mechanism of hypoxia-induced gene regulation via the HIF-HRE system. This has given hope for the development of novel therapeutic approaches against hypoxia in the kidney.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18269190     DOI: 10.1007/978-0-387-75434-5_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

2.  Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats.

Authors:  Peng Hu; Jing Wang; Xue Qi Zhao; Bo Hu; Ling Lu; Yuan Han Qin
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

3.  What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury.

Authors:  Erol Akpinar; Zekai Halici; Elif Cadirci; Yasin Bayir; Emre Karakus; Muhammet Calik; Atilla Topcu; Beyzagul Polat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-09       Impact factor: 3.000

4.  Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition.

Authors:  Anna Stein; Silvia Goldmeier; Sarah Voltolini; Enio Setogutti; Carlos Feldman; Eduardo Figueiredo; Renato Eick; Maria Irigoyen; Katya Rigatto
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

Review 5.  Blood oxygenation level-dependent MRI for assessment of renal oxygenation.

Authors:  Joel Neugarten; Ladan Golestaneh
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-11-21

Review 6.  Inflammation and Oxidative Damage in Ischaemic Renal Disease.

Authors:  Áine M de Bhailís; Constantina Chrysochou; Philip A Kalra
Journal:  Antioxidants (Basel)       Date:  2021-05-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.